Manufacturer

Biomerieux

9 recalls in our database name Biomerieux as the manufacturing or recalling firm.

What the numbers show

Total: 9
Critical: 1
Severe: 1
Most recent: 2015-12-30

Of the 9 recalls from Biomerieux we have scored against our rubric, 1 (11%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (11%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–9 of 9

CriticalFDA (Devices)·Z-0442-2016·2015-12-30
Biomerieux Etest PIP/TAZO/CON-4 PTC 256 Recalled for Erroneous Results
Biomerieux is recalling Etest PIP/TAZO/CON-4 PTC 256 antimicrobial susceptibility tests due to the potential for reporting false susceptible results for Piperacillin/Tazobactam.
Product
Etest¿ PIP/TAZO/CON-4 PTC 256 - Foam of 100 tests US. Etest¿ is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
SevereFDA (Devices)·Z-0440-2016·2015-12-30
Biomerieux Recalls Etest PIP/TAZO/CON-4 PTC Antimicrobial Susceptibility Tests
Biomerieux is recalling Etest PIP/TAZO/CON-4 PTC antimicrobial susceptibility tests due to the potential for reporting erroneous results, specifically false susceptible results for Piperacillin/Tazobactam.
Product
Etest¿ PIP/TAZO/CON-4 PTC 256 -pack of 30 tests US. Etest¿ is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Devices)·Z-0441-2016·2015-12-30
Biomerieux Recalls Etest PIP/TAZO/CON-4 PTC 256 Antimicrobial Susceptibility Tests
Biomerieux is recalling Etest PIP/TAZO/CON-4 PTC 256 antimicrobial susceptibility tests due to the potential for reporting false susceptible results for Piperacillin/Tazobactam.
Product
Etest¿ PIP/TAZO/CON-4 PTC 256 - Foam of 100 tests WW. Etest¿ is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
ModerateFDA (Devices)·Z-0439-2016·2015-12-30
Biomerieux Recalls Etest Piperacillin/Tazobactam Tests Due to False Results
Biomerieux is recalling Etest Piperacillin/Tazobactam tests because they may report false susceptible results for bacteria.
Product
Etest¿ Piperacillin/tazobactam (4 ug/mL) PTc0.016-256-pack of 30 tests WW Etest¿ is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
LowFDA (Devices)·Z-0232-2015·2014-11-26
Biomerieux Recalls Etest Ceftaroline Devices Due to Incorrect Expiration Date Labeling
Biomerieux is recalling 652 Etest Ceftaroline devices because the labeling displays a 5-year expiration period instead of the correct 2-year period.
Product
Etest¿ Ceftaroline (CPT32) US B30. Etest¿ (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
LowFDA (Devices)·Z-0234-2015·2014-11-26
Biomerieux Recalls Etest Ceftaroline Devices Due to Incorrect Expiration Date
Biomerieux is recalling 652 Etest Ceftaroline devices because the labeling displays a 5-year expiration instead of the correct 2-year period.
Product
Etest¿ Ceftaroline (CPT32) US B30. Etest¿ (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
LowFDA (Devices)·Z-0233-2015·2014-11-26
Biomerieux Recalls Etest Ceftaroline Devices Due to Incorrect Expiration Date
Biomerieux is recalling 652 Etest Ceftaroline devices because the labels list a 5-year expiration date instead of the correct 2-year date.
Product
Etest¿ Ceftaroline (CPT32) US B100. Etest¿ (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
LowFDA (Devices)·Z-0230-2015·2014-11-26
Biomerieux Recalls Etest Ceftaroline Devices Due to Incorrect Expiration Date Labeling
Biomerieux is recalling 652 Etest Ceftaroline devices because the labels list a 5-year expiration date instead of the correct 2-year date.
Product
Etest¿ Ceftaroline (CPT32) WW B30. Etest¿ (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide
LowFDA (Devices)·Z-0231-2015·2014-11-26
Biomerieux Recalls Etest Ceftaroline Devices Due to Incorrect Expiration Date
Biomerieux is recalling 652 Etest Ceftaroline devices because the labels list a 5-year expiration instead of 2 years.
Product
Etest¿ Ceftaroline (CPT32) WWB100. Etest¿ (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.
Category
Medical Device
Distribution
Distributed nationwide